ApiJect Systems America names new CEO
24 July 2020 -

ApiJect Systems America Inc, a United States-based public benefit corporation that is dedicated to making injectable medicines safe and available for everyone, and its subsidiary RAPID USA, have named Franco Negron as their new chief executive officer, effective6 July 2020, it was reported on Thursday.

Prior to joining his new role at both firms, Negron was president of Commercial Operations at Thermo Fisher Scientific. He was president of Development & Commercial, North America at Patheon Pharmaceuticals, which was later acquired by Thermo Fisher Scientific. He was designated president of Commercial Operations after the company's acquisition.

Negron has over 25 years of experience in the pharmaceutical industry, including as vice president of Manufacturing and Supply at Valeant Pharmaceuticals, global vice president in Novartis' Consumer Health Over-the-Counter and Pharmaceutical Products Division, and site general manager at McNeil Consumer Healthcare.

Negron is to replace ApiJect Systems America Inc, and RAPID USA co-founder, Jay Walker, who had been serving in the dual role of chairman and CEO.